Aftobetin-HCl and Fluorescence Detection Measured by Sapphire II to Determine the Number and Timing of Administrations
Conditions
- Mild Cognitive Impairment
- Alzheimer's Disease
Interventions
- DEVICE: Sapphire II
- DRUG: Aftobetin-HCl
- RADIATION: Positron Emission Tomography
Sponsor
Cognoptix, Inc.